Back to search results

Music Therapy for Blood Cancer Survivors with Cognitive Difficulties

This study is looking into whether music therapy can help blood cancer survivors who are having trouble with their thinking, memory, or attention (cognitive difficulties). Researchers will compare two approaches: Music Therapy/MT, which includes therapeutic music lessons and guided listening, and Therapist-Attention Music Education/TAME Control, where a music therapist guides participants through music activities. You might be able to join if you are 18 or older, have been diagnosed with lymphoma, leukemia, or myeloma, and have stable or no evidence of your cancer. The main goal is to see if a telehealth (online) music therapy program is practical to deliver, measured by how many sessions participants complete. The study is currently unclear about its recruitment status and plans to enroll 60 people.

Study design
This is an interventional study planning to enroll 60 participants. It compares two different music-based interventions.
What's involved
Participants will receive 12 weekly 60-minute sessions, with homework between sessions. The primary endpoint is measured for up to 1 year.
Compensation
Not stated in the trial record.
Follow-up
The feasibility of the intervention is measured for up to 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07052916

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Recruiting
NAAges 18+InterventionalTreatment
Memorial Sloan Kettering Cancer Center
~60 participants
Updated 2026-05-26 on ClinicalTrials.gov
What's tested:Music Therapy/MTTherapist-Attention Music Education/TAME Control

At a glance

Recruiting sites
7 of 7 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of studying a telehealth-based Music Therapy/MT intervention for cancer-related cognitive dysfunction/CRCD in hematologic cancer survivors as defined as the completion of 9 or more sessions.
Measured over up to 1 year

Conditions

Blood Cancer
Lymphoma
Leukemia
Myeloma

Explore related trials

LeukemiaLymphomaMultiple Myeloma

Where it's being run

7 sites across 2 states
New York4
New Jersey3

Study leadership

  • Kevin Liou, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

Kevin Liou, MD
[email protected]
646-608-8563
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English-proficient, aged 18 or older
Diagnosis of lymphoma, leukemia, or myeloma
Stable oncologic disease or no evidence of disease as indicated in the medical chart or by the oncology team
Score of \<54 on the FACT-Cog PCI subscale
Minimum life expectancy of one year as per clinician assessment
Patient should be able to understand and complete all study assessments on their own.
Eligible patient should be able to understand informed consent and provide signed informed consent in English.

Exclusion

Less than 3 months since completion of surgery, radiation, induction chemotherapy (for newly diagnosed or relapsed disease), transplantation, or immunotherapy (e.g., CAR T-Cell, bispecific antibodies)
If there is a defined treatment period, the patient must be at least 3 months from treatment completion
If the patient is on continuous therapy, patient must have completed at least 6 months of the therapy
Maintenance therapies are allowed
Received music therapy (MT) in the past year
Current music training, \>6 months of music training in the past 10 years, or plan to initiate music training during the study
No access to an internet-connected device
Active suicidal ideation, bipolar, schizophrenia, or substance abuse
BOMC score ≥10 (indicative of dementia)
Uncorrectable visual, auditory, or motor impairments
Initiation or altered dose of sedative, stimulant, or anti-cholinergic medications in the past month or plan to initiate these medications during the study, as these are known to impact cognitive function
Initiation of any other interventions for CRCD (e.g., cognitive rehabilitation) in the past month or plan to initiate these interventions during the study, as these are known to impact cognitive function

What this trial measures

  • Feasibility of studying a telehealth-based Music Therapy/MT intervention for cancer-related cognitive dysfunction/CRCD in hematologic cancer survivors as defined as the completion of 9 or more sessions.up to 1 year

    The primary objective of this study is to determine the feasibility of studying a telehealth-based Music Therapy/MT intervention for cancer-related cognitive dysfunction/CRCD in hematologic cancer survivors. Feasibility will be defined as the completion of 9 or more sessions out of the planned 12 weekly sessions of music therapy.